Immuno-Oncology 360° addresses business aspects, clinical advancements and scientific data for cancer immunotherapy that helps advance technology platforms to develop therapeutics at an accelerated rate. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.
Immuno-Oncology 360° provides 10 plenary sessions over the course of 3 days addressing:
Discovery / Preclinical Science
Translational Science & Biomarkers
Clinical Data Developments
Financial & Commercial Implications
Trends in the Field
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org